A European life science VC fund manager that invests across all healthcare verticals and stages, in products with the potential to address unmet medical needs.

Hadean Ventures

Hadean Ventures is a European life science fund manager with a particular focus on the Nordic region. Hadean Ventures invests broadly across the life science sector, including in speciality pharmaceuticals, medical technology, diagnostics and digital health. Hadean Ventures has offices in Oslo and Stockholm.

Themis Bioscience

Galecto

Abliva AB

Our investment analyst Yun Yang, MD MSc had the chance to participate in a recent EIC ePitching event on MedTech and share her insight in an article. Thank you European Innovation Council and SMEs Executive Agency (EISMEA) for your continuous support in highlighting emerging MedTech companies in Europe.
#HadeanVentures #EISMEA #VentureCapital

Great day for our team event - kayaking on the Oslo-fjord enjoying the sunny weather and testing our skills! Happy summer 😊 #Hadeanventures #teambuilding #lifesciencevc

Great news from our portfolio company Attgeno, that successfully compleated their Phase II study for Supernitro. Congratulations! 
#Attgeno #HadeanVentures #VentureCapital

Thank you Tesi for letting us contribute to this article, and for being a great investor and partner for life science investments! 
#Tesi #HadeanVentures #lifescience #venturecapital

Hadean Ventures is pleased to announce that we have co-led a €63 million Series A financing round for SciRhom, a Munich-based Immunology & Inflammation (I&I) company. We were joined by co-lead investors Andera Partners, Kurma Partners, MIG Capital, and Wellington Partners, additional new investor Bayern Kapital, as well as existing investors.
 
Dr. Georgina Askeland, PhD, Senior Associate at Hadean Ventures, will join SciRhom’s Board of Directors.
 
“SciRhom has a unique approach that ticks all the boxes in I&I. In one stroke, their highly selective iRhom2 antibody targets a central pathway to cytokine release, shutting down multiple pathological inflammatory pathways while simultaneously promoting immune tolerance pathways. This could have transformative potential for patients with inflammatory and autoimmune diseases and we are excited to support the company to validate this clinically.”, says Dr. Georgina Askeland.

#HadeanVentures #SciRhom #VentureCapital #LifeScience

Good news! Hadean Ventures portfolio company Oncoinvent ASA receives FDA Fast Track Designation for lead candidate Radspherin!
#radiopharma #oncoinvent #hadeanventures #lifesciencevc 

https://lnkd.in/dEZgg8vD

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 12, 2024 1:41 AM	5266f3b5
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 12, 2024 7:04 PM	57ccda89
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 12, 2024 1:41 AM	32d759b8
translate crunchbase fundingrounds	general
peers	general	Jul 12, 2024 1:41 AM	559a5c99
news basic	general	Jul 12, 2024 1:41 AM	ed36f022
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

HADE

COM:HADEANVENTURES

Hadean Ventures